| Endometriosis Research and Treatment | Lifetime | 9 | IT 3 | 99.80 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 32 | IT 5 | 99.67 |
| Uterine Myomas and Treatments | Lifetime | 24 | IT 7 | 99.71 |
| Ovarian cancer diagnosis and treatment | Lifetime | 65 | IT 6 | 99.57 |
| Gynecological conditions and treatments | Lifetime | 31 | IT 6 | 99.40 |
| Reproductive Health and Contraception | Lifetime | 44 | IT 2 | 98.72 |
| Cancer Risks and Factors | Lifetime | 86 | IT 6 | 99.28 |
| Gestational Trophoblastic Disease Studies | Lifetime | 31 | IT 2 | 98.55 |
| Cervical Cancer and HPV Research | Lifetime | 236 | IT 10 | 98.79 |
| Ectopic Pregnancy Diagnosis and Management | Lifetime | 72 | IT 4 | 98.79 |
| Birth, Development, and Health | Lifetime | 469 | IT 6 | 98.63 |
| Menstrual Health and Disorders | Lifetime | 43 | IT 3 | 98.10 |
| Pregnancy and preeclampsia studies | Lifetime | 514 | IT 15 | 98.22 |
| Estrogen and related hormone effects | Lifetime | 511 | IT 18 | 98.10 |
| Reproductive System and Pregnancy | Lifetime | 480 | IT 21 | 97.52 |
| Ovarian function and disorders | Lifetime | 400 | IT 29 | 98.16 |
| Assisted Reproductive Technology and Twin Pregnancy | Lifetime | 406 | IT 20 | 97.57 |
| Global Cancer Incidence and Screening | Lifetime | 824 | IT 26 | 96.55 |
| Pregnancy and Medication Impact | Lifetime | 428 | IT 15 | 95.61 |
| Prenatal Screening and Diagnostics | Lifetime | 784 | IT 36 | 96.30 |
| Menopause: Health Impacts and Treatments | Lifetime | 235 | IT 10 | 95.81 |
| COVID-19 Impact on Reproduction | Lifetime | 340 | IT 25 | 93.49 |
| Sexual function and dysfunction studies | Lifetime | 493 | IT 57 | 95.50 |
| Gestational Diabetes Research and Management | Lifetime | 949 | IT 22 | 95.08 |
| Pregnancy-related medical research | Lifetime | 543 | IT 19 | 94.33 |
| Maternal and fetal healthcare | Lifetime | 910 | IT 23 | 94.24 |
| Coffee research and impacts | Lifetime | 937 | IT 53 | 83.08 |
| Demographic Trends and Gender Preferences | Lifetime | 952 | IT 14 | 81.81 |
| Pregnancy and preeclampsia studies | 2021-2025 | 567 | IT 26 | 92.91 |
| Assisted Reproductive Technology and Twin Pregnancy | 2021-2025 | 206 | IT 23 | 92.89 |
| Cancer Risks and Factors | 2021-2025 | 252 | IT 13 | 89.31 |
| Ovarian function and disorders | 2021-2025 | 653 | IT 58 | 87.19 |
| Reproductive Health and Technologies | 2021-2025 | 744 | IT 59 | 81.19 |
| Gynecological conditions and treatments | 2021-2025 | 457 | IT 85 | 75.44 |
| Family Dynamics and Relationships | 2021-2025 | 983 | IT 46 | 45.74 |
| Demographic Trends and Gender Preferences | 2021-2025 | 676 | IT 14 | 42.13 |
